Table 2.

Main radiotracers performances in gliomas recurrence distinction and in discriminating recurrence from post-therapeutic modifications.

	Sensitivity %	Specificity %	Positive predictive value %	Negative predictive value %	Accuracy %
18F-FDG	43–100 (29, 42, 68, 77, 78, 100, 152)	40–100 (29, 42, 68, 77, 78, 100, 152)	80–00 (100, 152)	20–38.9 (100, 152)	60.7 (100)
11C-choline and 18F-Fcholine	73.5–92.3% (68, 77)	87.5% (68, 77)	NA	NA	NA
11C-methionine	75–91.2% (77, 78)	87.5–100 (77, 78)	NA	NA	NA
18F-FDOPA	84–100 (95, 100, 101)	62.1–100 (95, 100, 101)	89.6–100 (95, 100, 101)	63.4–100 (95, 100, 101)	78–97 (95, 100, 101)
18F-FET	84–100 (126, 128–130)	86–100 (126, 128–130)	84–100 (125, 128)	NA	85–96 (128–130)
18F-FLT	82.1 (152)	50 (152)	73.3 (152)	26.7 (152)	NA